Search results
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 3 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
Pfizer agrees to settle over 10,000 Zantac lawsuits
New Hampshire Union Leader· 4 days agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported...
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga· 4 days agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s PFE experimental gene...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports By Reuters
Investing.com· 4 days agoThe agreements cover cases in U.S. state courts but don't completely resolve the company's exposure...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 3 days agoWhich dividend stocks are worth buying in the current market? Telecom giant AT&T (NYSE: T) and pharmaceutical titan Pfizer (NYSE: PFE) scan as incredible...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 1 day agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Pfizer's Options Frenzy: What You Need to Know - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Excellent Ratings for Pfizer's Property Captive in Vermont Are Affirmed
Insurance Journal· 2 days agoAM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit...
Pfizer reports patient death in Duchenne gene therapy study
KFGO· 5 days ago(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 4 days agoHere is why Johnson & Johnson (JNJ -0.21%), Abbott Labs (ABT 0.04%), and Pfizer (PFE -0.55%) should...